Treatment of symptomatic uterine fibroids with orally active gonadotropin-releasing hormone antagonists and add-back therapy

被引：0
|
作者：
Felberbaum, Ricardo [1 ]
Kupker, Wolfgang [2 ]
Diedrich, Klaus [3 ]
机构：
[1] Klinikverbund Allgau gGmbH, Klin Frauenheilkunde & Geburtshilfe, Klinikum Kempten & Klin Immenstadt, KinderWunschKempten KWK,Zent Gynakol Endokrinol &, Robert Weixler Str 50, D-87439 Kempten, Germany
[2] IVF Baden Baden, Zent Reprod Med & Gynakol Endokrinol, Baden Baden, Germany
[3] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde & Geburtshilfe, Campus Lubeck, Lubeck, Germany
来源：
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2023年 / 21卷 / 02期
关键词：
LEIOMYOMAS;
D O I：
10.1007/s10304-023-00505-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：128 / 131
页数：4
相关论文
共 50 条
  • [1] Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids
    Morris, Edward Patrick
    Rymer, Janice
    Robinson, Jill
    Fogelman, Ignac
    FERTILITY AND STERILITY, 2008, 89 (02) : 421 - 428
  • [2] Behandlung symptomatischer uteriner Myome mit oral aktiven Gonadotropin-Releasing-Hormon-Antagonisten und Add-back-TherapieTreatment of symptomatic uterine fibroids with orally active gonadotropin-releasing hormone antagonists and add-back therapy
    Ricardo Felberbaum
    Wolfgang Küpker
    Klaus Diedrich
    Gynäkologische Endokrinologie, 2023, 21 (2) : 128 - 131
  • [3] Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata
    Nakayama, H
    Yano, T
    Sagara, Y
    Kikuchi, A
    Ando, K
    Wang, Y
    Watanabe, M
    Matsumi, H
    Osuga, Y
    Momoeda, M
    Taketani, Y
    GYNECOLOGICAL ENDOCRINOLOGY, 1999, 13 (06) : 382 - 389
  • [4] Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?
    Surrey, ES
    FERTILITY AND STERILITY, 1999, 71 (03) : 420 - 424
  • [5] Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and ''add-back'' therapy
    Murray, SC
    Muse, KN
    FERTILITY AND STERILITY, 1997, 67 (02) : 390 - 393
  • [6] Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
    Surrey, Eric S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (04) : 283 - 288
  • [7] Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia
    Agorastos, T
    Vaitsi, V
    Paschopoulos, M
    Vakiani, A
    Zournatzi-Koiou, V
    Saravelos, H
    Kostopoulou, E
    Constantinidis, T
    Dinas, K
    Vavilis, D
    Lolis, D
    Bontis, JB
    MATURITAS, 2004, 48 (02) : 125 - 132
  • [8] Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy
    Mizutani, T
    Sugihara, A
    Honma, H
    Komura, H
    Nakamuro, K
    Terada, N
    GYNECOLOGICAL ENDOCRINOLOGY, 2005, 20 (02) : 80 - 83
  • [9] Eliminating Hormones With Orally Active Gonadotropin-releasing Hormone Antagonists
    Kotlyar, Alexander M.
    Pal, Lubna
    Taylor, Hugh S.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2021, 64 (04): : 837 - 849
  • [10] TREATMENT OF UTERINE FIBROIDS WITH AGONIST ANALOGS OF GONADOTROPIN-RELEASING HORMONE
    KESSEL, B
    LIU, J
    MORTOLA, J
    BERGA, S
    YEN, SSC
    FERTILITY AND STERILITY, 1988, 49 (03) : 538 - 541
12345